Dr. Schindler is Assistant Professor of Neurology at Yale School of Medicine and a board-certified Neurologist and Headache Medicine specialist. Among her efforts to optimize the management of headache disorders, she has developed and executed the first controlled trials of the effects of psilocybin in headache disorders. Previously, Dr. Schindler studied the neuropharmacology of psychedelics and other serotonergic compounds in the context of receptor binding and intracellular signaling. Her neuropharmacology background frames her endeavor to investigate the potential for psychedelics to serve as safe and effective therapeutic agents in headache disorders. Currently, she seeks to identify the source of sustained reductions in headache burden after limited dosing of psychedelic and related compounds, considering several neurobiological systems.